Waris Gulam, Felmlee Daniel Jeffery, Negro Francesco, Siddiqui Aleem
Department of Medicine, Division of Infectious Diseases, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
J Virol. 2007 Aug;81(15):8122-30. doi: 10.1128/JVI.00125-07. Epub 2007 May 16.
Hepatic steatosis is a common histological feature of chronic hepatitis C. Hepatitis C virus (HCV) gene expression has been shown to alter host cell cholesterol/lipid metabolism and thus induce hepatic steatosis. Since sterol regulatory element binding proteins (SREBPs) are major regulators of lipid metabolism, we sought to determine whether genotype 2a-based HCV infection induces the expression and posttranslational activation of SREBPs. HCV infection stimulates the expression of genes related to lipogenesis. HCV induces the proteolytic cleavage of SREBPs. HCV core and NS4b derived from genotype 3a are also individually capable of inducing the proteolytic processing of SREBPs. Further, we demonstrate that HCV stimulates the phosphorylation of SREBPs. Our studies show that HCV-induced oxidative stress and subsequent activation of the phosphatidylinositol 3-kinase (PI3-K)-Akt pathway and inactivation (phosphorylation) of PTEN (phosphatase and tensin homologue) mediate the transactivation of SREBPs. HCV-induced SREBP-1 and -2 activities were sensitive to antioxidant (pyrrolidine dithiocarbamate), Ca(2+) chelator 1,2-bis(aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-tetra(acetoxymethyl) ester (BAPTA-AM), and PI3-K inhibitor (LY294002). Collectively, these studies provide insight into the mechanisms of hepatic steatosis associated with HCV infection.
肝脂肪变性是慢性丙型肝炎常见的组织学特征。丙型肝炎病毒(HCV)基因表达已被证明会改变宿主细胞胆固醇/脂质代谢,从而诱发肝脂肪变性。由于固醇调节元件结合蛋白(SREBPs)是脂质代谢的主要调节因子,我们试图确定基于2a基因型的HCV感染是否会诱导SREBPs的表达和翻译后激活。HCV感染会刺激与脂肪生成相关的基因表达。HCV会诱导SREBPs的蛋白水解切割。源自3a基因型的HCV核心蛋白和NS4b也各自能够诱导SREBPs的蛋白水解加工。此外,我们证明HCV会刺激SREBPs的磷酸化。我们的研究表明,HCV诱导的氧化应激以及随后磷脂酰肌醇3激酶(PI3-K)-Akt途径的激活和PTEN(磷酸酶和张力蛋白同源物)的失活(磷酸化)介导了SREBPs的反式激活。HCV诱导的SREBP-1和-2活性对抗氧化剂(吡咯烷二硫代氨基甲酸盐)、Ca(2+)螯合剂1,2-双(氨基苯氧基)乙烷-N,N,N',N'-四乙酸-四(乙酰氧基甲基)酯(BAPTA-AM)和PI3-K抑制剂(LY294002)敏感。总的来说,这些研究为深入了解与HCV感染相关的肝脂肪变性机制提供了线索。